NMTC (STOCKS)
NeuroOne Medical Technologies Corporation Common Stock
$1.761700
+0.241700 (+15.90%)
Prev close: $1.520000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Medical Specialties
- CEO
- David A. Rosa
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $16.06M
- Employees
- 17
- P/E (TTM)
- -1.83
- P/B (TTM)
- 2.58
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
3
Strong Buy
5
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Sep 2026 (Q3)
|
$-0.28 | $-0.22 | -0.0590 | -26.70% |
|
Mar 2026 (Q2)
|
$-0.25 | $-0.23 | -0.0188 | -8.13% |
|
Dec 2025 (Q1)
|
$-0.18 | $-0.24 | +0.0648 | +26.47% |
|
Sep 2025 (Q4)
|
$-0.24 | $-0.24 | +0.0048 | +1.96% |
Financial Statements
| Revenues | $9.72M |
| Benefits Costs and Expenses | $16.36M |
| Cost Of Revenue | $4.42M |
| Costs And Expenses | $16.36M |
| Gross Profit | $5.30M |
| Operating Expenses | $12.36M |
| Selling, General, and Administrative Expenses | $7.21M |
| Depreciation and Amortization | $256.47K |
| Research and Development | $5.16M |
| Operating Income/Loss | -$7.07M |
| Income/Loss From Continuing Operations After Tax | -$6.64M |
| Income/Loss From Continuing Operations Before Tax | -$6.64M |
| Net Income/Loss | -$6.64M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$6.64M |
| Net Income/Loss Available To Common Stockholders, Basic | -$6.64M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$0.35 |
| Diluted Earnings Per Share | -$0.51 |
| Basic Average Shares | 110,723,519 |
| Diluted Average Shares | 110,723,519 |
| Assets | $7.86M |
| Current Assets | $7.40M |
| Inventory | $1.87M |
| Prepaid Expenses | $283.72K |
| Other Current Assets | $5.25M |
| Noncurrent Assets | $461.16K |
| Fixed Assets | $230.60K |
| Intangible Assets | $33.79K |
| Other Non-current Assets | $196.78K |
| Liabilities | $2.49M |
| Current Liabilities | $1.69M |
| Accounts Payable | $934.20K |
| Other Current Liabilities | $755.26K |
| Noncurrent Liabilities | $801.87K |
| Equity | $5.37M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $5.37M |
| Liabilities And Equity | $7.86M |
| Net Cash Flow From Operating Activities | -$7.43M |
| Net Cash Flow From Operating Activities, Continuing | -$7.43M |
| Net Cash Flow From Investing Activities | -$133.43K |
| Net Cash Flow From Investing Activities, Continuing | -$133.43K |
| Net Cash Flow From Financing Activities | $9.05M |
| Net Cash Flow From Financing Activities, Continuing | $9.05M |
| Net Cash Flow | $1.48M |
| Net Cash Flow, Continuing | $1.48M |
| Comprehensive Income/Loss | -$6.64M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$6.64M |
| Other Comprehensive Income/Loss | $0.00 |